SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:umu-31421"
 

Search: onr:"swepub:oai:DiVA.org:umu-31421" > Neurological and ge...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Neurological and general outcome in low-risk coronary artery bypass patients using heparin coated circuits

Svenmarker, S. (author)
Umeå universitet,Kirurgi
Sandström, E. (author)
Umeå universitet,Anestesiologi och intensivvård
Karlsson, T. (author)
show more...
Häggmark, S. (author)
Umeå universitet,Anestesiologi och intensivvård
Jansson, E. (author)
Umeå universitet,Institutionen för kirurgisk och perioperativ vetenskap
Appelblad, M. (author)
Umeå universitet,Institutionen för kirurgisk och perioperativ vetenskap
Lindholm, R. (author)
Umeå universitet,Institutionen för kirurgisk och perioperativ vetenskap
Åberg, T. (author)
Umeå universitet,Kirurgi
show less...
 (creator_code:org_t)
Oxford : Oxford University Press, 2001
2001
English.
In: European Journal of Cardio-Thoracic Surgery. - Oxford : Oxford University Press. - 1010-7940 .- 1873-734X. ; 19:1, s. 47-53
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Objective: The clinical significance of heparin coating in cardiopulmonary bypass has previously been investigated. However, few studies have addressed the possible influence on brain function and memory disturbances. Methods: Three hundred low-risk patients exposed to coronary bypass surgery were randomised into three groups according to type of heparin coating: Carmeda Bioactive Surface, Baxter Duraflo II and a control group. Outcome was determined from a number of clinically oriented parameters, including a detailed registry of postoperative deviations from the normal postoperative course. Brain damage was assessed through S100 release and memory tests, including a questionnaire follow-up. Results: Clinical outcome was similar for all groups. Blood loss (Duraflo only), transfusion requirements and postoperative creatinine elevation were reduced in the heparin-coated groups. A lower incidence of atrial fibrillation was noted in the Duraflo group. Heparin coating did not uniformly attenuate the release of S100 or the degree of memory impairment. Conclusions: Cardiopulmonary bypass (CPB) with heparin coating and a reduced dose of heparin seems to be safe. Clinical outcome and neurological injury seem not to be associated with type of heparin coating used for CPB. However, blood loss and transfusion requirements may be reduced.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Kardiologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cardiac and Cardiovascular Systems (hsv//eng)

Keyword

Amnesia/etiology
Blood Loss
Surgical/physiopathology
Blood Transfusion
Brain Damage
Chronic/etiology
Cardiopulmonary Bypass/*instrumentation
*Coated Materials
Biocompatible
Coronary Artery Bypass/*instrumentation
Female
*Heparin
Humans
Male
Middle Aged
*Neurologic Examination
Neuropsychological Tests
Postoperative Complications/*etiology
Prospective Studies
Risk Factors
S100 Proteins/blood

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view